BACKGROUND: HIV-infected patients commonly use complementary and alternative medicine (CAM), but it is not known how often CAM is used as a complement or as a substitute for conventional HIV therapy. OBJECTIVES: To evaluate the prevalence and factors associated with CAM use with potential for adverse effects and CAM substitution for conventional HIV medication. DESIGN AND PARTICIPANTS: Cross-sectional survey of U.S. national probability sample of HIV-infected patients (2,466 adults) in care from December 1996 to July 1997. MAIN OUTCOME VARIABLES: Any CAM use, CAM use with potential for adverse effects, and use of CAM as a substitute for conventional HIV therapy. Substitution was defined as replacement of some or all conventional HIV medications with CAM. RESULTS: Fifty-three percent of patients had recently used at least one type of CAM. One quarter of patients used CAM with the potential for adverse effects, and one-third had not discussed such use with their health care provider. Patients with a greater desire for medical information and involvement in medical decision making and with a negative attitude toward antiretrovirals were more likely to use CAM. Three percent of patients substituted CAM for conventional HIV therapy. They were more likely to desire involvement in medical decision-making (odds ratio, 1.8; 95% confidence interval, 1.0-3.2) and to have a negative attitude toward antiretrovirals (odds ratio, 7.8; 95% confidence interval, 3.0-19.0). CONCLUSIONS: Physicians should openly ask HIV-infected patients about CAM use to prevent adverse effects and to identify CAM substitution for conventional HIV therapy.
BACKGROUND:HIV-infectedpatients commonly use complementary and alternative medicine (CAM), but it is not known how often CAM is used as a complement or as a substitute for conventional HIV therapy. OBJECTIVES: To evaluate the prevalence and factors associated with CAM use with potential for adverse effects and CAM substitution for conventional HIV medication. DESIGN AND PARTICIPANTS: Cross-sectional survey of U.S. national probability sample of HIV-infectedpatients (2,466 adults) in care from December 1996 to July 1997. MAIN OUTCOME VARIABLES: Any CAM use, CAM use with potential for adverse effects, and use of CAM as a substitute for conventional HIV therapy. Substitution was defined as replacement of some or all conventional HIV medications with CAM. RESULTS: Fifty-three percent of patients had recently used at least one type of CAM. One quarter of patients used CAM with the potential for adverse effects, and one-third had not discussed such use with their health care provider. Patients with a greater desire for medical information and involvement in medical decision making and with a negative attitude toward antiretrovirals were more likely to use CAM. Three percent of patients substituted CAM for conventional HIV therapy. They were more likely to desire involvement in medical decision-making (odds ratio, 1.8; 95% confidence interval, 1.0-3.2) and to have a negative attitude toward antiretrovirals (odds ratio, 7.8; 95% confidence interval, 3.0-19.0). CONCLUSIONS: Physicians should openly ask HIV-infectedpatients about CAM use to prevent adverse effects and to identify CAM substitution for conventional HIV therapy.
Authors: Nancy L McCain; D Patricia Gray; R K Elswick; Jolynne W Robins; Inez Tuck; Jeanne M Walter; Sarah M Rausch; Jessica McKinney Ketchum Journal: J Consult Clin Psychol Date: 2008-06
Authors: Karl Peltzer; Natalie Friend-du Preez; Shandir Ramlagan; Henry Fomundam; Jane Anderson Journal: Afr J Tradit Complement Altern Med Date: 2009-12-30
Authors: Rakhi Kohli; Robert S Klein; Ellie E Schoenbaum; Kathryn Anastos; Howard Minkoff; Henry S Sacks Journal: J Urban Health Date: 2006-01 Impact factor: 3.671
Authors: Mónica M Calderón; Cheryl L Chairez; Lori A Gordon; Raul M Alfaro; Joseph A Kovacs; Scott R Penzak Journal: Pharmacotherapy Date: 2014-08-20 Impact factor: 4.705
Authors: An-Fu Hsiao; Ron D Hays; Gery W Ryan; Ian D Coulter; Ronald M Andersen; Mary L Hardy; David L Diehl; Ka-Kit Hui; Neil S Wenger Journal: Health Serv Res Date: 2005-10 Impact factor: 3.402
Authors: Anne Marie Belz Chomat; Ira B Wilson; Christine A Wanke; A Selvakumar; K R John; Rita Isaac Journal: AIDS Patient Care STDS Date: 2009-06 Impact factor: 5.078